Category

Definition

Type of presumptive and code used

F1: failure of initial treatment

Previously treated for TB and whose initial treatment failed at the end. With positive smear after 5 month of treatment.

F2: failure of retreatment

Previously treated for TB and whose retreatment failed at the end. With positive smear after 5 month of treatment.

F3: failure of a 3^rd treatment

Previously treated for TB and whose a 3^RD treatment failed at the end.

R1: relapse after initial treatment

Previously treated for TB, were declared cured or treatment completed at the end of initial treatment, and are now diagnosed with a recurrent episode of TB.

R2: relapse after retreatment

Previously treated for TB, were declared cured or treatment completed at the end of retreatment, and are now diagnosed with a recurrent episode of TB.

R3: relapse after 3 or more treatment

Previously treated for TB, were declared cured or treatment completed at the end of a 3^RD treatment, and are now diagnosed with a recurrent episode of TB.

OT: other previously treated

previously treated for TB but whose outcome after their most recent course of treatment is unknown or undocumented

D1: return after default to initial treatment

Previously treated for TB and were recognized lost to follow-up during the initial treatment.

D2: return after default to retreatment

Previously treated for TB and were recognized lost to follow-up during the retreatment.

D3: return after default to a 3^rd treatment

Previously treated for TB and were recognized lost to follow-up during a 3^RD or more treatment. This is at least a third episode.

C2: Sputum smears positive at the end of intensive phase of initial treatment

Patient who remain sputum-smear positive at 2 month of initial treatment.

NC: case of MDR-TB patient contact

Exposure to a known RR-/MDR-TB case. Often family contact, with 2 months at least have lived closely (or promiscuous) with a patient with RR-/MDR-TB.

HIV: Person living with HIV Aids

Person living with HIV Aids

Results of sensitivity test

Monoresistance

Resistance to a TB only of first-line drug other than Rifampicin

Polyresistance

Resistance to more than one anti-TB first-line drug without combining rifampicin and isoniazid.

Multi drug resistant tuberculosis (MDR - TB)

Combined resistance to rifampicin and isoniazid with or without others.

Tuberculosis in susceptible bacilli

Sensitivity to rifampicin and isoniazid

Resistance to rifampicin (RR)

Resistance to rifampicin detected using genotypic, phenotypic methods with or without resistance to other drugs.

Multi drug resistant and resistant to rifampicin (RR-/MDR-TB)

Sets of the phenotypic and genotypic test-confirmed cases of RR-/MDR-TB. This includes any form of resistance to rifampicin, the patterns, the polyrésistance and the MDR-TB.